These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 3260356)
1. Immunosuppression with monoclonal antibodies in multiple sclerosis. Hafler DA; Weiner HL Neurology; 1988 Jul; 38(7 Suppl 2):42-7. PubMed ID: 3260356 [TBL] [Abstract][Full Text] [Related]
2. Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effects and human anti-mouse responses. Hafler DA; Ritz J; Schlossman SF; Weiner HL J Immunol; 1988 Jul; 141(1):131-8. PubMed ID: 2454256 [TBL] [Abstract][Full Text] [Related]
3. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes. Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954 [TBL] [Abstract][Full Text] [Related]
4. In vivo labeling of blood T cells: rapid traffic into cerebrospinal fluid in multiple sclerosis. Hafler DA; Weiner HL Ann Neurol; 1987 Jul; 22(1):89-93. PubMed ID: 3498435 [TBL] [Abstract][Full Text] [Related]
5. Human immune response to multiple injections of murine monoclonal IgG. Shawler DL; Bartholomew RM; Smith LM; Dillman RO J Immunol; 1985 Aug; 135(2):1530-5. PubMed ID: 3874237 [TBL] [Abstract][Full Text] [Related]
6. Treating multiple sclerosis with monoclonal antibodies: the cons. Champlin RE Neurology; 1988 Jul; 38(7 Suppl 2):47-9. PubMed ID: 3260357 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies in human organ transplantation and auto-immune diseases. Wijdenes J; Roy C; Morel-Fourrier B; Racadot E Therapie; 1992; 47(4):283-7. PubMed ID: 1494788 [TBL] [Abstract][Full Text] [Related]
8. Immunosuppression in progressive multiple sclerosis with high dose intravenous cyclophosphamide and monoclonal antibodies. Dawson DM; Carter JL; Hafler DA; Weiner HL Riv Neurol; 1987; 57(2):88-91. PubMed ID: 3039645 [TBL] [Abstract][Full Text] [Related]
9. In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice. Blazar BR; Taylor PA; Vallera DA J Immunol; 1994 Apr; 152(7):3665-74. PubMed ID: 8144942 [TBL] [Abstract][Full Text] [Related]
10. Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans. Rep MH; van Oosten BW; Roos MT; Adèr HJ; Polman CH; van Lier RA J Clin Invest; 1997 May; 99(9):2225-31. PubMed ID: 9151795 [TBL] [Abstract][Full Text] [Related]
11. A novel murine model for the assessment of human CD2-related reagents in vivo. Ding Y; Qin L; Yang Q; Punch JD; Fox DA; Hochman PS; Bromberg JS J Immunol; 1996 Sep; 157(5):1863-9. PubMed ID: 8757303 [TBL] [Abstract][Full Text] [Related]
12. Helplessness as a strategy for avoiding antiglobulin responses to therapeutic monoclonal antibodies. Isaacs JD; Waldmann H Ther Immunol; 1994 Dec; 1(6):303-12. PubMed ID: 7584505 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody treatment of human allograft recipients. Delmonico FL; Cosimi AB Surg Gynecol Obstet; 1988 Jan; 166(1):89-98. PubMed ID: 3276014 [TBL] [Abstract][Full Text] [Related]
14. An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity. Alegre ML; Tso JY; Sattar HA; Smith J; Desalle F; Cole M; Bluestone JA J Immunol; 1995 Aug; 155(3):1544-55. PubMed ID: 7636216 [TBL] [Abstract][Full Text] [Related]
15. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2. Lin J; Yon RW; Chavin KD; Qin L; Woodward J; Ding Y; Yagita H; Bromberg JS Transplantation; 1995 Apr; 59(8):1162-71. PubMed ID: 7537394 [TBL] [Abstract][Full Text] [Related]
16. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A. Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181 [TBL] [Abstract][Full Text] [Related]
17. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction. Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399 [TBL] [Abstract][Full Text] [Related]
18. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones. Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760 [TBL] [Abstract][Full Text] [Related]
19. Depletion of CD8+ T lymphocytes by murine monoclonal CD8 antibodies and restored specific T cell proliferation in vivo in a patient with chronic hepatitis C. Kiefersauer S; Reiter C; Eisenburg J; Diepolder HM; Rieber EP; Riethmüller G; Gruber R J Immunol; 1997 Oct; 159(8):4064-71. PubMed ID: 9378996 [TBL] [Abstract][Full Text] [Related]
20. Contrasting in vivo effects on T helper cell functions induced by mitogenic (intact) versus nonmitogenic (F(ab')2) anti-CD3 monoclonal antibody. Sawchuk SS; Gates R; Hirsch R Transplantation; 1995 Dec; 60(11):1331-7. PubMed ID: 8525530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]